Dean Gentle

2.7k total citations
29 papers, 1.8k citations indexed

About

Dean Gentle is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Dean Gentle has authored 29 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Dean Gentle's work include Epigenetics and DNA Methylation (20 papers), Renal cell carcinoma treatment (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Dean Gentle is often cited by papers focused on Epigenetics and DNA Methylation (20 papers), Renal cell carcinoma treatment (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Dean Gentle collaborates with scholars based in United Kingdom, Japan and United States. Dean Gentle's co-authors include Eamonn R. Maher, Farida Latif, Mark R. Morris, Masahiro Yao, Takeshi Kishida, Christopher J. Ricketts, Noel W. Clarke, Dewi Astuti, Victoria Hill and M.D. Brown and has published in prestigious journals such as Cancer Research, Oncogene and Human Molecular Genetics.

In The Last Decade

Dean Gentle

29 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dean Gentle United Kingdom 26 1.4k 506 472 193 188 29 1.8k
Amanda Prowse United Kingdom 14 940 0.7× 761 1.5× 420 0.9× 245 1.3× 197 1.0× 17 1.5k
Franclim R. Ribeiro Portugal 23 1.1k 0.8× 628 1.2× 921 2.0× 302 1.6× 226 1.2× 38 1.8k
Betty Gardie France 15 803 0.6× 516 1.0× 238 0.5× 194 1.0× 135 0.7× 36 1.3k
Ubaradka G. Sathyanarayana United States 17 1.1k 0.8× 323 0.6× 498 1.1× 276 1.4× 104 0.6× 22 1.4k
Eiwa Ishida Japan 24 930 0.7× 297 0.6× 260 0.6× 356 1.8× 85 0.5× 52 1.4k
Patricia Fergelot France 23 666 0.5× 320 0.6× 579 1.2× 249 1.3× 133 0.7× 70 1.6k
Yeqing Angela Yang United States 13 1.2k 0.8× 774 1.5× 441 0.9× 333 1.7× 123 0.7× 17 1.8k
Chisato Nakada Japan 24 1.4k 1.0× 865 1.7× 267 0.6× 160 0.8× 107 0.6× 44 2.0k
Jennifer A. Doll United States 21 921 0.7× 371 0.7× 261 0.6× 363 1.9× 192 1.0× 29 1.6k
Yutaka Tokumaru Japan 19 991 0.7× 301 0.6× 207 0.4× 391 2.0× 112 0.6× 50 1.4k

Countries citing papers authored by Dean Gentle

Since Specialization
Citations

This map shows the geographic impact of Dean Gentle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean Gentle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean Gentle more than expected).

Fields of papers citing papers by Dean Gentle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean Gentle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean Gentle. The network helps show where Dean Gentle may publish in the future.

Co-authorship network of co-authors of Dean Gentle

This figure shows the co-authorship network connecting the top 25 collaborators of Dean Gentle. A scholar is included among the top collaborators of Dean Gentle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean Gentle. Dean Gentle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brini, A.T., Jessica Bauer, Seley Gharanei, et al.. (2015). Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas. Epigenetics. 10(3). 213–220. 21 indexed citations
2.
Ricketts, Christopher J., Mark R. Morris, Dean Gentle, et al.. (2013). Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma. Clinical Epigenetics. 5(1). 16–16. 35 indexed citations
3.
Shinawi, Thoraia, Victoria Hill, Dietmar Krex, et al.. (2013). DNA methylation profiles of long- and short-term glioblastoma survivors. Epigenetics. 8(2). 149–156. 93 indexed citations
4.
Alokail, Majed S., Dean Gentle, Masahiro Yao, et al.. (2013). DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma. Epigenetics. 8(3). 252–267. 34 indexed citations
5.
Brini, A.T., Seley Gharanei, Sumathi Vaiyapuri, et al.. (2013). Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma. Epigenetics. 8(11). 1198–1204. 36 indexed citations
6.
Hill, Victoria, Christopher J. Ricketts, Ivan Bièche, et al.. (2011). Genome-Wide DNA Methylation Profiling of CpG Islands in Breast Cancer Identifies Novel Genes Associated with Tumorigenicity. Cancer Research. 71(8). 2988–2999. 126 indexed citations
7.
Astuti, Dewi, Christopher J. Ricketts, Rasheduzzaman Chowdhury, et al.. (2010). Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility. Endocrine Related Cancer. 18(1). 73–83. 48 indexed citations
8.
Dunwell, Thomas L., Luke B. Hesson, Tibor A. Rauch, et al.. (2010). A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Molecular Cancer. 9(1). 44–44. 84 indexed citations
9.
Hill, Victoria, Dietmar Krex, Katja Robel, et al.. (2010). Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis. Oncogene. 30(8). 978–989. 47 indexed citations
10.
Hill, Victoria, Luke B. Hesson, Temuujin Dansranjavin, et al.. (2010). Identification of 5 novel genes methylated in breast and other epithelial cancers. Molecular Cancer. 9(1). 51–51. 65 indexed citations
11.
Morris, Mark R., Christopher J. Ricketts, Dean Gentle, et al.. (2010). Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene. 30(12). 1390–1401. 166 indexed citations
12.
McRonald, Fiona E., Mark R. Morris, Dean Gentle, et al.. (2009). CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma. Molecular Cancer. 8(1). 31–31. 65 indexed citations
13.
Morris, Mark R., Dewi Astuti, Dean Gentle, et al.. (2008). Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma. Endocrine Related Cancer. 15(3). 777–786. 22 indexed citations
14.
Abdulrahman, Mahera, Mark R. Morris, Elena Prigmore, et al.. (2007). Characterization of a 3;6 translocation associated with renal cell carcinoma. Genes Chromosomes and Cancer. 46(4). 311–317. 26 indexed citations
15.
Morris, Mark R., Dean Gentle, Mahera Abdulrahman, et al.. (2005). Tumor Suppressor Activity and Epigenetic Inactivation of Hepatocyte Growth Factor Activator Inhibitor Type 2/SPINT2 in Papillary and Clear Cell Renal Cell Carcinoma. Cancer Research. 65(11). 4598–4606. 95 indexed citations
16.
Astuti, Dewi, Dean Gentle, Wendy N. Cooper, et al.. (2005). Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas. Endocrine Related Cancer. 12(1). 161–172. 55 indexed citations
17.
Gissen, Paul, Colin A. Johnson, Dean Gentle, et al.. (2005). Comparative evolutionary analysis of VPS33 homologues: genetic and functional insights. Human Molecular Genetics. 14(10). 1261–1270. 45 indexed citations
18.
Morris, Mark R., Esther N. Maina, Neil V. Morgan, et al.. (2004). Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma. Journal of Clinical Pathology. 57(7). 706–711. 56 indexed citations
19.
Astuti, Dewi, Mark R. Morris, Cecilia Krona, et al.. (2004). Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma. British Journal of Cancer. 91(10). 1835–1841. 37 indexed citations
20.
Astuti, Dewi, Ashraf Dallol, Dean Gentle, et al.. (2004). SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma. British Journal of Cancer. 90(2). 515–521. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda Prowse Breakdown of academic impact, for papers by Franclim R. Ribeiro Breakdown of academic impact, for papers by Betty Gardie Breakdown of academic impact, for papers by Ubaradka G. Sathyanarayana Breakdown of academic impact, for papers by Eiwa Ishida Breakdown of academic impact, for papers by Patricia Fergelot Breakdown of academic impact, for papers by Yeqing Angela Yang Breakdown of academic impact, for papers by Chisato Nakada Breakdown of academic impact, for papers by Jennifer A. Doll Breakdown of academic impact, for papers by Yutaka Tokumaru
Rankless by CCL
2026